Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 5
Submit an article Journal homepage
1,516
Views
18
CrossRef citations to date
0
Altmetric
Review

Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines

Rui Sun Department of Pathology; Institute of Basic Medical Sciences; Chinese Academy of Medical Sciences; School of Basic Medicine; Peking Union Medical College; Beijing, P.R. China
&
Yuqin Liu Department of Pathology; Institute of Basic Medical Sciences; Chinese Academy of Medical Sciences; School of Basic Medicine; Peking Union Medical College; Beijing, P.R. China; Cell Resource Center; Institute of Basic Medical Sciences; Chinese Academy of Medical Sciences; School of Basic Medicine; Peking Union Medical College; Beijing, P.R. ChinaCorrespondence[email protected]
Pages 1058-1068 | Received 30 Nov 2012, Accepted 03 Feb 2013, Published online: 11 Feb 2013

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ritika Chatterjee, Atish Roy Chowdhury, Debapriya Mukherjee & Dipshikha Chakravortty. (2021) Lipid larceny: channelizing host lipids for establishing successful pathogenesis by bacteria. Virulence 12:1, pages 195-216.
Read now
Tatiana Galicia-Carmona, Eder Arango-Bravo, Juan a Serrano-Olvera, Celia Flores-de La Torre, Ivan Cruz-Esquivel, Ricardo Villalobos-Valencia, Andrés Morán-Mendoza, Denisse Castro-Eguiluz & Lucely Cetina-Pérez. (2021) ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer. Human Vaccines & Immunotherapeutics 17:8, pages 2617-2625.
Read now
Hector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, Isabel García, Marco Marradi, Javier Freire, Erwan Salmon, Mar Portillo-Gonzalez, Elisabet Frande-Cabanes, Almudena García-Castaño, Virginia Martinez-Callejo, Javier Gomez-Roman, Raquel Tobes, Fernando Rivera, Sonsoles Yañez-Diaz & Carmen Álvarez-Domínguez. (2019) Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma. OncoImmunology 8:2.
Read now

Articles from other publishers (15)

Jugal Kishore Das & Aryashree Arunima. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics 231 247 .
A. del Valle, N. Acosta-Rivero, R.J. Laborde, Y. Cruz-Leal, S. Cabezas, M.C. Luzardo, C. Alvarez, M. Labrada, A. Rodríguez, G.L. Rodríguez, J. Raymond, C.V. Nogueira, D. Grubaugh, L.E. Fernández, D. Higgins & M.E. Lanio. (2021) Sticholysin II shows similar immunostimulatory properties to LLO stimulating dendritic cells and MHC-I restricted T cell responses of heterologous antigen. Toxicon 200, pages 38-47.
Crossref
Nejc Petrišič, Mirijam Kozorog, Saša Aden, Marjetka Podobnik & Gregor Anderluh. (2021) The molecular mechanisms of listeriolysin O-induced lipid membrane damage. Biochimica et Biophysica Acta (BBA) - Biomembranes 1863:7, pages 183604.
Crossref
Nataša Resnik, Larisa Tratnjek, Mateja Erdani Kreft, Matic Kisovec, Saša Aden, Apolonija Bedina Zavec, Gregor Anderluh, Marjetka Podobnik & Peter Veranič. (2021) Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells. International Journal of Molecular Sciences 22:7, pages 3305.
Crossref
Rady J. Laborde, Mayari E. Ishimura, Lianne Abreu-Butin, Catarina V. Nogueira, Daniel Grubaugh, Yoelys Cruz-Leal, María C. Luzardo, Audry Fernández, Circe Mesa, Fabiola Pazos, Carlos Álvarez, María E. Alonso, Michael N. Starnbach, Darren E. Higgins, Luis E. Fernández, Ieda M. Longo-Maugéri & María E. Lanio. (2021) Sticholysins, pore-forming proteins from a marine anemone can induce maturation of dendritic cells through a TLR4 dependent-pathway. Molecular Immunology 131, pages 144-154.
Crossref
Peter L. Stern. 2021. Cancer Immunology. Cancer Immunology 543 562 .
Ramesh Cheerla & K. Ganapathy Ayappa. (2020) Molecular Dynamics Study of Lipid and Cholesterol Reorganization Due to Membrane Binding and Pore Formation by Listeriolysin O. The Journal of Membrane Biology 253:6, pages 535-550.
Crossref
Christopher C. Phelps, Stephen Vadia, Prosper N. Boyaka, Sanjay Varikuti, Zayed Attia, Purnima Dubey, Abhay R. Satoskar, Rodney Tweten & Stephanie Seveau. (2020) A listeriolysin O subunit vaccine is protective against Listeria monocytogenes. Vaccine 38:36, pages 5803-5813.
Crossref
John FlickingerJr.Jr., Ulrich Rodeck & Adam Snook. (2018) Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress. Vaccines 6:3, pages 48.
Crossref
Brett A. Miles, Bradley J. Monk & Howard P. Safran. (2017) Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy. Gynecologic Oncology Research and Practice 4:1.
Crossref
Shin-ichiro Fujii & Kanako Shimizu. (2017) Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells. Frontiers in Immunology 8.
Crossref
R. Calderon-Gonzalez, H. Terán-Navarro, I. García, M. Marradi, D. Salcines-Cuevas, S. Yañez-Diaz, A. Solis-Angulo, E. Frande-Cabanes, M. C. Fariñas, A. Garcia-Castaño, J. Gomez-Roman, S. Penades, F. Rivera, J. Freire & C. Álvarez-Domínguez. (2017) Gold glyconanoparticles coupled to listeriolysin O 91–99 peptide serve as adjuvant therapy against melanoma. Nanoscale 9:30, pages 10721-10732.
Crossref
Ricardo Calderon-Gonzalez, Lucia Bronchalo-Vicente, Javier Freire, Elisabet Frande-Cabanes, Lidia Alaez-Alvarez, Javier Gomez-Roman, Sonsóles Yañez-Diaz & Carmen Alvarez-Dominguez. (2016) Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma . Oncotarget 7:13, pages 16855-16865.
Crossref
Stefan Köster, Katharina van Pee, Martina Hudel, Martin Leustik, Daniel Rhinow, Werner Kühlbrandt, Trinad Chakraborty & Özkan Yildiz. (2014) Crystal structure of listeriolysin O reveals molecular details of oligomerization and pore formation. Nature Communications 5:1.
Crossref
Stephanie Seveau. 2014. MACPF/CDC Proteins - Agents of Defence, Attack and Invasion. MACPF/CDC Proteins - Agents of Defence, Attack and Invasion 161 195 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.